Affibody

View the org chart displaying its 16 main executives

Most searched biographies at Affibody

• David Bejker, Chief Executive Officer
• Michael Monaghan, Board Director, Employee Representative
• Mathias Uhlén, Vice Chairman of the Board

Popular executive movements at Affibody

• Peter Zerhouni, who was Chief Business Officer, is promoted to Chief Financial Officer  (posted on October 4 2023).

Create your alert
to follow the executive moves at Affibody.

Affibody has 2,275 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Histogen has filed for bankruptcy protection  (posted on April 19 2024).
• Bruker has announced the acquisition of NanoString Technologies  (posted on April 18 2024).
• Vertex Pharmaceuticals has announced the acquisition of Alpine Immune Sciences  (posted on April 16 2024).

Popular contacts in Biotechnology

• Vik Bajaj - Director at Interline Therapeutics
• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Affibody

Social media about Affibody

• Affibody on Wikipedia, Google News & Yahoo Finance
• Affibody on LinkedIn, Twitter & YouTube

Contact by email its executives including David Bejker

Call Affibody at +46 85...

View the org chart

Register to receive your alert

Report an error